Indaptus Therapeutics, Inc.
Develops bacterial-based immunotherapies for cancer and viral infections.
INDP | US
Overview
Corporate Details
- ISIN(s):
- US45339J1051
- LEI:
- Country:
- United States of America
- Address:
- 3 COLUMBUS CIRCLE, 10019 NEW YORK
- Website:
- https://indaptusrx.com/
Description
Indaptus Therapeutics, Inc. is a clinical-stage biotechnology company that develops immunotherapies for cancer and viral infections. The company's proprietary platform is based on a patented approach that uses engineered, attenuated, and killed non-pathogenic gram-negative bacteria to activate the immune system. This technology, known as Decoy20, is designed to harness the natural ability of bacteria to engage both innate and adaptive immune pathways. By systemically administering these agents, Indaptus aims to stimulate a broad immune response against tumors and virally infected cells. The company's approach has demonstrated anti-tumor and anti-viral activity in pre-clinical models.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Indaptus Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Indaptus Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Indaptus Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
